Showing 7341-7350 of 9826 results for "".
- Takeda Completes Acquisition of Nimbus’ TYK2 Subsidiaryhttps://practicaldermatology.com/news/takeda-completes-acquisition-of-nimbus-tyk2-subsidiary/2461552/Takeda has expanded its psoriasis treatment portfolio after completing its acquisition of Nimbus Lakshmi from Nimbus Therapeutics in a deal worth up to $6 billion. Under the agreement, which was announced on December 13, 2022, Takeda will acquire TAK-279, formerly known at Nim
- Spotlight on: Lanolin Allergenicityhttps://practicaldermatology.com/news/spotlight-on-lanolin-allergenicity/2461531/The phenomenon of lanolin allergenicity is the focus of the Contact Allergen of the Year article in <
- Amazon Launches $5-a-Month Subscription Service for Generic Drugshttps://practicaldermatology.com/news/amazon-launches-5-a-month-subscription-service-for-generic-drugs-1/2461518/In its latest move into the healthcare and pharmacy business, Amazon announced the launch of RxPass, a new benefit for Prime members that offers patients access to commonly prescribed generic medications that treat more than 80 heal
- Can the Sunshine Vitamin Lower Melanoma Risk?https://practicaldermatology.com/news/can-the-sunshine-vitamin-lower-melanoma-risk/2461490/
- MyHealthTeam and Arcutis Biotherapeutics Launch Social Network for People Living with Seborrheic Dermatitishttps://practicaldermatology.com/news/myhealthteam-and-arcutis-biotherapeutics-launch-social-network-for-people-living-with-seborrheic-dermatitis/2461454/
- James R. Headley Joins ELEVAI LABS as Strategic Advisorhttps://practicaldermatology.com/news/james-r-headley-joins-elevai-labs-as-strategic-advisor-a-strategic-advisor/2461450/Cosmetic industry veteran James R. Headley is joining
- Almirall Joins Project Aimed at Giving Clinical Trial Data Back to Study Participantshttps://practicaldermatology.com/news/almirall-joins-project-aimed-at-giving-clinical-trial-data-back-to-study-participants/2461446/Almirall is participating in FACILITATE (FrAmework for ClInicaL trIal participants’ daTA reutilization for a fully Transparent and Ethical ecosystem), a patient-driven Innovative Medicines Initiative (IMI) project that aims to create a framework for access and reutilization of clinical tria
- #NationalMenopauseDay Launch: VICHY Laboratoires Introduces Neovadiol Meno 5 Serumhttps://practicaldermatology.com/news/national-menopause-day-launch-vichy-laboratoires-introduces-neovadiol-meno-5-serum/2461388/VICHY Laboratoires is launching
- ASDSA Names 2022 Patient Safety Hero Awardeeshttps://practicaldermatology.com/news/asdsa-names-2022-patient-safety-hero-awardees/2461379/Mathew Avram, MD, JD and Joel Cohen, MD received the
- Almirall, Simcere Enter Into Licensing Agreement for IL-2-mu-Fchttps://practicaldermatology.com/news/almirall-simcere-enter-into-licensing-agreement-for-il-2-mu-fc/2461365/